Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment
Business Wire•22/10/2026•16:30 ET
0
Key Highlights
- ➤Charles River, Labcorp, and FDA establish joint research framework for abuse-potential screening
- ➤Charles River will apply behavioral-economic models to self-administration data
- ➤Charles River has conducted over 100 abuse-potential studies
- ➤Charles River contributed to abuse-potential assessments for 15 FDA-approved products
Expert Statements
Namandjé N. Bumpus, Chief Science and Innovation Officer, Charles River
“Assessing abuse potential is essential for identifying risks and ensuring the safety of new drugs”
Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment
Joint research effort seeks to improve abuse potential assessment tools to support drug development and public health decision-making
Get started
Create a free account to read the full story.